Logo Waystar Holding Corp

Waystar Holding Corp (WAY) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026
Waystar Holding Corp · Health Care · ref. ETF XLV · 51 calls · price $26.3
🔔Price alertsCreate an alert →
What the company does: Waystar Holding Corp. develops a cloud-based software solution for healthcare payments.

📈 Waystar Holding Corp (WAY) stock price

$26.3-28.2% over range
Oct 14, 25low $17.31 · high $39.62Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
91% recommend buying · 11 analysts
📊 JPI status : Waystar Holding Corp has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 WAY price target & analyst consensus — price $26.30

The price target · all analysts combined (11 targets)
Highest target · 1 firm of 11$44+67.3%
Median target · of 11 targets$33+25.5%
Lowest target · 3 firms of 11$30+14.1%
Current price$26.3
Where these 11 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 11100% $30 ↔ $44
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 59% of its targets hit on this sector (76 calls tested). It aims for $33 (+26 %), call made on July 31, 2026, maturing on July 31, 2027 (75 d ago).

The 1 reliable analyst $33+26 %
The 10 other firms $33+26 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $33 median. “The 10 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 11 ratings (last 6 months)
Strong Buy00%
Buy1091%
Hold19%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Waystar Holding Corp? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on WAY

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕ % right i ↕ Gain vs sector i ↕ Calls i ↕
Deutsche Bank ↗ 100% +61.8% 2
JP Morgan ↗ 100% +56.7% 2
Raymond James ↗ 100% +49.8% 2
RBC Capital ↗ 100% +48.9% 3
Evercore ISI Group ↗ 100% +43.3% 4
B of A Securities ↗ 67% +35.3% 3
Goldman Sachs ↗ 50% +8.8% 4
Canaccord Genuity ↗ 40% -2.0% 5
Barclays ↗ 25% -2.0% 4
Truist Securities ↗ 0% -40.9% 3

📊 What $1,000 invested in Waystar Holding Corp would be worth › open the full page

In short — $1,000 invested in Waystar Holding Corp 10 years ago would be worth $1,072 today, i.e. +4%/yr on average. Best year: 2025 (-15%), worst: 2025 (-15%). Price performance, excluding dividends.

If I'd invested $1,000 in Waystar Holding Corp

InvestmentWorth todayGain
1 years ago$600-40%
→ See Waystar Holding Corp's full return history + gain calculator

Return by year (Waystar Holding Corp)

YearReturn$1,000 invested at year start
2026 (YTD)-29%$707 (-29%)
2025-15%$600 (-40%)
→ See Waystar Holding Corp's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Waystar Holding Corp

Loading news…

📋 All analyst calls on WAY

▲ Buy · 🎯$32
Price at call : $26.59 — upside +20%
Today : $26.3 — upside +22%
🎯 on WAY : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 16, 27
Barclays ↗
Sep 15, 26
■ Equal-Weight neutral · not a buy · 🎯$30
Price at call : $26.59 — gap to target +13%
Today : $26.3 — gap to target +14%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Sep 15, 27
▲ Buy · 🎯$33
Price at call : $26.18 — upside +26%
Today : $26.3 — upside +25%
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Aug 31, 27
RBC Capital ↗
Aug 27, 26
▲ Outperform · 🎯$44
Price at call : $26.24 — upside +68%
Today : $26.3 — upside +67%
🎯 on WAY : no call matured yet · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Aug 27, 27
Needham ↗
Aug 26, 26
▲ Buy · 🎯$33
Price at call : $24.17 — upside +37%
Today : $26.3 — upside +25%
🎯 on WAY : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Aug 26, 27
▲ Buy · 🎯$33
Price at call : $24.78 — upside +33%
Today : $26.3 — upside +25%
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Aug 13, 27
Barclays ↗
Aug 7, 26
▲ Overweight · 🎯$27
Price at call : $24.7 — upside +9%
Today : $26.3 — upside +3%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Aug 7, 27
UBS ↗
Jul 30, 26
▲ Buy · 🎯$33
Price at call : $21.11 — upside +56%
Today : $26.3 — upside +25%
🎯 on WAY : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Jul 30, 27
See the other 43 calls, newest to oldest
Wells Fargo ↗
Jul 30, 26
▲ Overweight · 🎯$33
Price at call : $21.11 — upside +56%
Today : $26.3 — upside +25%
🎯 on WAY : no call matured yet · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Jul 30, 27
Needham ↗
Jul 30, 26
▲ Buy · 🎯$33
Price at call : $20.94 — upside +58%
Today : $26.3 — upside +25%
🎯 on WAY : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Jul 30, 27
Keybanc ↗
Jul 2, 26
▲ Overweight · 🎯$30
Price at call : $23.46 — upside +28%
Today : $26.3 — upside +14%
🎯 on WAY : no call matured yet · 📊 on Health : 23.6% · -18.3% (110 calls)
in progress (365j)
matures : Jul 2, 27
Barclays ↗
May 20, 26
▲ Overweight · 🎯$25
Price at call : $18.83 — upside +33%
Today : $26.3 — upside -5%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : May 20, 27
Citigroup ↗
May 5, 26
▲ Buy · 🎯$30
Price at call : $19.9 — upside +51%
Today : $26.3 — upside +14%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : May 5, 27
JP Morgan ↗
May 1, 26
▲ Overweight · 🎯$38
Price at call : $20.95 — upside +81%
Today : $26.3 — upside +44%
🎯 on WAY : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : May 1, 27
UBS ↗
Apr 30, 26
▲ Buy · 🎯$37
Price at call : $20.95 — upside +77%
Today : $26.3 — upside +41%
🎯 on WAY : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Apr 30, 27
Needham ↗
Apr 30, 26
▲ Buy · 🎯$33
Price at call : $21.38 — upside +54%
Today : $26.3 — upside +25%
🎯 on WAY : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Apr 30, 27
▲ Buy · 🎯$38
Price at call : $21.5 — upside +77%
Today : $26.3 — upside +44%
🎯 on WAY : no call matured yet · 📊 on Health : 51.9% · +3.9% (156 calls)
in progress (365j)
matures : Apr 10, 27
Morgan Stanley ↗
Mar 30, 26
■ Equal-Weight neutral · not a buy · 🎯$28
Price at call : $24.11 — gap to target +16%
Today : $26.3 — gap to target +6%
🎯 on WAY : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Mar 30, 27
Deutsche Bank ↗
Mar 12, 26
▲ Buy · 🎯$37
Price at call : $24.16 — upside +53%
Today : $26.3 — upside +41%
🎯 on WAY : no call matured yet · 📊 on Health : 33.9% · -7.0% (56 calls)
in progress (365j)
matures : Mar 12, 27
Wells Fargo ↗
Feb 19, 26
▲ Overweight · 🎯$36
Price at call : $25.07 — upside +44%
Today : $26.3 — upside +37%
🎯 on WAY : no call matured yet · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Feb 19, 27
▲ Buy · 🎯$30
Price at call : $25.79 — upside +16%
Today : $26.3 — upside +14%
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Feb 18, 27
Citigroup ↗
Feb 18, 26
▲ Buy · 🎯$35
Price at call : $25.79 — upside +36%
Today : $26.3 — upside +33%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Feb 18, 27
BMO Capital ↗
Feb 18, 26
▲ Outperform · 🎯$30
Price at call : $25.79 — upside +16%
Today : $26.3 — upside +14%
🎯 on WAY : no call matured yet · 📊 on Health : 43.3% · -2.2% (67 calls)
in progress (365j)
matures : Feb 18, 27
Goldman Sachs ↗
Feb 18, 26
▲ Buy · 🎯$38
Price at call : $25.79 — upside +47%
Today : $26.3 — upside +44%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 51.9% · +5.8% (104 calls)
in progress (365j)
matures : Feb 18, 27
Barclays ↗
Feb 18, 26
▲ Overweight · 🎯$36
Price at call : $25.79 — upside +40%
Today : $26.3 — upside +37%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Feb 18, 27
▲ Buy · 🎯$38
Price at call : $25.79 — upside +47%
Today : $26.3 — upside +44%
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Feb 18, 27
▲ Outperform · 🎯$27
Price at call : $25.41 — upside +6%
Today : $26.3 — upside +3%
🎯 on WAY : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Feb 18, 27
▲ Buy · 🎯$33
Price at call : $25.41 — upside +30%
Today : $26.3 — upside +25%
🎯 on WAY : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 18, 27
Needham ↗
Feb 17, 26
▲ Buy · 🎯$33
Price at call : $25.41 — upside +30%
Today : $26.3 — upside +25%
🎯 on WAY : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Feb 17, 27
Citigroup ↗
Jan 9, 26
▲ Buy · 🎯$46
Price at call : $31.59 — upside +46%
Today : $26.3 — upside +75%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Jan 9, 27
Wells Fargo ↗
Jan 9, 26
▲ Overweight · 🎯$41
Price at call : $34.5 — upside +19%
Today : $26.3 — upside +56%
🎯 on WAY : no call matured yet · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Jan 9, 27
UBS ↗
Dec 15, 25
▲ Buy · 🎯$41
Price at call : $32.9 — upside +25%
Today : $26.3 — upside +56%
🎯 on WAY : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Dec 15, 26
Barclays ↗
Dec 9, 25
▲ Overweight · 🎯$42
Price at call : $30.4 — upside +38%
Today : $26.3 — upside +60%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Dec 9, 26
■ Hold neutral · not a buy · 🎯$40
Price at call : $35.74 — gap to target +12%
Today : $26.3 — gap to target +52%
🎯 on WAY : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 21, 26
BMO Capital ↗
Nov 13, 25
▲ Outperform · 🎯$47
Price at call : $35.75 — upside +31%
Today : $26.3 — upside +79%
🎯 on WAY : no call matured yet · 📊 on Health : 43.3% · -2.2% (67 calls)
in progress (365j)
matures : Nov 13, 26
Needham ↗
Nov 11, 25
▲ Buy · 🎯$46
Price at call : $36.03 — upside +28%
Today : $26.3 — upside +75%
🎯 on WAY : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Nov 11, 26
Citigroup ↗
Oct 31, 25
▲ Buy · 🎯$49
Price at call : $37.03 — upside +32%
Today : $26.3 — upside +86%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Oct 31, 26
▲ Buy · 🎯$54
Price at call : $35.85 — upside +51%
Today : $26.3 — upside +105%
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Oct 30, 26
Mizuho ↗
Oct 30, 25
▲ Outperform · 🎯$50
Price at call : $37.06 — upside +35%
Today : $26.3 — upside +90%
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Oct 30, 26
JMP Securities
Sep 18, 25
▲ Market Outperform · 🎯$48
Price at call : $38.58 — upside +24%
Today : $26.3 — upside +83%
Expected +24% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (1 call matured) · 📊 unranked overall
-33.5%
stock -33% · XLV +22%
matured Sep 18, 26
Baird ↗
Sep 5, 25
▲ Outperform · 🎯$44
Price at call : $37.27 — upside +18%
Today : $26.3 — upside +67%
Expected +18% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 38.1% · -2.9% (84 calls)
-35.0%
stock -35% · XLV +21%
matured Sep 5, 26
▲ Buy · 🎯$51
Price at call : $36.7 — upside +39%
Today : $26.3 — upside +94%
Expected +39% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-39.8%
stock -40% · XLV +21%
matured Jul 17, 26
Mizuho ↗
Jun 30, 25
▲ Outperform · 🎯$48
Price at call : $39.4 — upside +22%
Today : $26.3 — upside +83%
Expected +22% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 27.3% · -9.0% (88 calls)
-45.6%
stock -46% · XLV +17%
matured Jun 30, 26
Citigroup ↗
Jun 25, 25
▲ Buy · 🎯$45
Price at call : $39.27 — upside +15%
Today : $26.3 — upside +71%
Expected +15% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
-49.3%
stock -49% · XLV +19%
matured Jun 25, 26
▲ Buy · 🎯$50
Price at call : $40.01 — upside +25%
Today : $26.3 — upside +90%
Expected +25% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-50.3%
stock -50% · XLV +8%
matured May 8, 26
▲ Buy · 🎯$47
Price at call : $40.68 — upside +16%
Today : $26.3 — upside +79%
Expected +16% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-48.7%
stock -49% · XLV +4%
matured May 1, 26
Barclays ↗
Apr 14, 25
▲ Overweight · 🎯$45
Price at call : $36.93 — upside +22%
Today : $26.3 — upside +71%
Expected +22% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 37% · -8.6% (154 calls)
-33.2%
stock -33% · XLV +7%
matured Apr 14, 26
▲ Buy · 🎯$45
Price at call : $36.47 — upside +23%
Today : $26.3 — upside +71%
Expected +23% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-32.5%
stock -33% · XLV +4%
matured Mar 14, 26
▲ Buy · 🎯$50
Price at call : $42.07 — upside +19%
Today : $26.3 — upside +90%
Expected +19% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (2 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-40.0%
stock -40% · XLV +7%
matured Feb 24, 26
Goldman Sachs ↗
Feb 19, 25
▲ Buy · 🎯$52
Price at call : $41 — upside +27%
Today : $26.3 — upside +98%
Expected +27% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on WAY : 0% (1 call matured) · 📊 on Health : 51.9% · +5.8% (104 calls)
-38.9%
stock -39% · XLV +7%
matured Feb 19, 26
William Blair ↗
Jul 2, 24
▲ Outperform
Actual +83% · Reason (≥ +15%) : ✓ Yes
🎯 on WAY : 100% (1 call matured) · 📊 on Health : 32% · -10.8% (25 calls)
+83.0%
stock +83% · XLV -5%
matured Jul 2, 25

Frequently asked questions

Should I buy Waystar Holding Corp stock?

This isn't buy advice. For Waystar Holding Corp, the analyst consensus is "Buy", with an average price target of $33.00 (+25% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Waystar Holding Corp). We show the numbers — you decide.

Is it too late to buy Waystar Holding Corp? How high can it go?

The most bullish analyst target on Waystar Holding Corp is $44.00 (+67% above today's price); the average is $33.00. That's the upside they see. Check how reliable those analysts have actually been on Waystar Holding Corp on our site before trusting it.

Is Waystar Holding Corp still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 10 analysts have a real record on Waystar Holding Corp, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.

Will Waystar Holding Corp stock recover (go back up)?

It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will WAY stock recover (go back up)?

Should you invest in Waystar Holding Corp? The case for and against

The arguments for and against, one by one, from the numbers: why invest in WAY (and why hesitate).

What has Waystar Holding Corp's past performance been?

Historical returns and a "how much if I had invested" calculator: WAY performance & returns.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)